Suspended and Revoked Manufacturing and Wholesale Distribution Authorisations by MHRA

This page provides a comprehensive list of Manufacturing and Wholesale Distribution authorisations that have been suspended or revoked by the Medicines and Healthcare products Regulatory Agency (MHRA). These actions are taken to ensure public safety and maintain the integrity of the UK’s healthcare system.

Mitigate risk with our comprehensive screening solutions for your AML and sanctions compliance.
98 Entities in Suspended and Revoked Manufacturing and Wholesale Distribution Authorisations by MHRA
Entity NameEntity TypeEffective DateStatus

Lynx Pharma Limited

CompanyJan 23, 2023inactive

PropharmaUK Limited

CompanyNov 29, 2024inactive

ACCENDO PHARMA LIMITED

CompanyDec 16, 2021active

HEDIGEN LIMITED

CompanyDec 18, 2020active

Simply Meds Pro Limited

CompanyMar 17, 2023active

Simply Meds Pro Limited

CompanyAug 24, 2022inactive

ACOMED LIMITED

CompanyMay 18, 2015active

HEALTHCARE EQUIPMENT AND SUPPLIES COMPANY LIMITED

CompanyJun 13, 2018active

Sciensus Pharma Services Limited

CompanyJul 11, 2023active

HQM Distribution Limited

CompanySep 20, 2024inactive

FAQs

Why is compliance with Suspended Medicaid Providers by Nevada Department of Health and Human Services necessary?

It is crucial to comply with the list of Suspended Medicaid Providers published by the Nevada Department of Health and Human Services. This list identifies healthcare providers who are no longer allowed to participate in the medicaid program due to various issues, including fraud, misconduct, or failure to meet regulatory standards.

Which companies should comply with Suspended Medicaid Providers by Nevada Department of Health and Human Services?

Healthcare providers and organizations offering Medicaid services in Nevada must comply with the suspended Medicaid providers list. This includes hospitals, clinics, and individual practitioners. Ensuring compliance is crucial to prevent financial penalties and protect the integrity of Medicaid programs. Non-compliance can lead to loss of funding and damage the reputation of healthcare providers.